ArticleNeurobiology of aging2011
Epigenetic mechanisms in Alzheimer's disease: progress but much to do.
Article in Neurobiology of aging, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Hypermethylation ofOxidative medicine and cellular longevity · 2018Article
- Age-related Disturbances in DNA (hydroxy)methylation in APP/PS1 Mice.Translational neuroscience · 2018Article
- Alterations in global DNA methylation and hydroxymethylation are not detected in Alzheimer's disease.Neuropathology and applied neurobiology · 2015Article
- Correlation of Alzheimer's disease death rates with historical per capita personal income in the USA.PloS one · 2015Article
- Common dysregulation network in the human prefrontal cortex underlies two neurodegenerative diseases.Molecular systems biology · 2014Article
- Epigenetic studies in Alzheimer's disease: current findings, caveats, and considerations for future studies.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2013Review
- New Perspectives on How to Discover Drugs from Herbal Medicines: CAM's Outstanding Contribution to Modern Therapeutics.Evidence-based complementary and alternative medicine : eCAM · 2013Article
- Epigenetic control on cell fate choice in neural stem cells.Protein & cell · 2012Review
Corrections and comments
- Commented on by
- Comment on
Authors and funding
3 authors.
Funding
Abstract
The interesting review from Mastroeni and colleagues highlights recent progress on epigenetic analysis of Alzheimer's disease, but it also illustrates how much we still need to do.
Indexed as
Identifiers
21669333What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.